| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8442582 | European Journal of Cancer | 2015 | 7 Pages |
Abstract
TM-ILP remains a very effective treatment modality for limb threatening extremity STS. Moreover, reduction of dose and the growing experience in ILP led to less local toxicity and shorter hospital stay.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jan P. Deroose, Dirk J. Grünhagen, Johannes H.W. de Wilt, Alexander M.M. Eggermont, Cornelis Verhoef,